Barclays PLC Evolent Health, Inc. Transaction History
Barclays PLC
- $854 Billion
- Q3 2025
A detailed history of Barclays PLC transactions in Evolent Health, Inc. stock. As of the latest transaction made, Barclays PLC holds 204,635 shares of EVH stock, worth $855,374. This represents 0.0% of its overall portfolio holdings.
Number of Shares
204,635
Previous 1,125,105
81.81%
Holding current value
$855,374
Previous $12.7 Million
86.34%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding EVH
# of Institutions
276Shares Held
130MCall Options Held
323KPut Options Held
211K-
Cadian Capital Management, LP New York, NY11.7MShares$49 Million5.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA11MShares$45.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.69MShares$36.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY7.98MShares$33.4 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA6.29MShares$26.3 Million0.98% of portfolio
About Evolent Health, Inc.
- Ticker EVH
- Exchange NYSE
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 97,063,696
- Market Cap $406M
- Description
- Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical pl...